Bali Zero
  • Home
  • Visa
  • Tax
  • Property
Get Started
KBLI Navigator/Section C/21011
KBLI 21011

Human Pharmaceutical Raw Material Manufacturing

Industri Bahan Baku Farmasi untuk Manusia

🏭 Section C — Manufacturing

In Bali: open to a PT PMA

✅Open· 100% ForeignHigh RiskDirect Match🏝️✅Registrable in Bali· medium conf.✓OSS-verified · KBLI 2025

KBLI 21011: Pharmaceutical Raw Materials for Human Medicine

A precise classification for making and processing human pharmaceutical ingredients, nationally open to PMA and not blocked by Bali’s moratorium record.

By the numbers
Foreign ownership ceiling
100%
PMA status
TERBUKA
Scales open to
Mikro, Kecil, Menengah, Besar
Bali status
Registrable in Bali
The honest read is therefore simple: KBLI 21011 is nationally foreign-open, and the Bali moratorium data supplied here does not block PMA registration for it.
What Changed

Direct 1:1 match from KBLI 2020 — code and scope unchanged.

What You Need

Foreign-owned companies (PMA) are allowed 100% ownership for this KBLI nationally, and it is not blocked by Bali’s moratorium on certain businesses. However, due to its medium-high to high risk classification, successful company registration in Bali is not automatic and will depend on verifying the specific location address—you may face additional scrutiny or require permits tied to the chosen premises.

Who This Is For

This suits foreign pharmaceutical ingredient manufacturers, biotech firms developing vaccines or blood-derived products, or natural-extract processors looking to set up a production base in Bali.

Licensing Overview
Risk LevelTinggi
License TypeNIB + Izin
Foreign Ownership100% Open
Processing7 working days
2020 → 2025
Previous codes (KBLI 2020): 21011
BPS crosswalk
Official BPS 2020 → 2025 crosswalk ancestors: 21011

Source: the BPS 2020↔2025 conversion table, mechanically extracted and acceptance-gate verified. It shows which 2020 codes map to this 2025 code — provenance only, not a licensing claim: the regulatory regime of these predecessor codes has not been adjudicated as transferring.

Sources & Verification

Each data layer below traces to a government source with its KBLI vintage — or is declared as a gap. Nothing in these layers is silently filled in.

Activity definition
BPS Peraturan 7/2025 + PP 28/2025VerifiedKBLI 2025

Title and scope as defined by the KBLI-2025 classification.

locator: OSS_RBA_2025_id_version_fff4053d

Risk & licensing
OSS RBA risk scope (ruang lingkup)VerifiedKBLI 2025

Risk category and licensing rows are KBLI-2025-native from the OSS Risk-Based Approach catalog.

locator: OSS_RBA_resiko_2025

Foreign ownership (PMA)
Perpres 10/2021, 49/2021Audit pendingKBLI 2020

The investment-list annexes predate KBLI 2025; the per-code crosswalk audit of this layer is in progress. The value shown is the annex text, disclosed with its vintage.

Bali status
Bali province blocks ALL Low + Medium-Low risk KBLI for PMA (island-wide, permanent) (effective 2026-05-13)Audit pending2026 overlay

Conservative posture derived from the risk tier · confidence MEDIUM.

Dataset last updated 2026-07-26 · KBLI 2020 and KBLI 2025 reuse code numbers for different activities — cross-vintage rows are labeled, never merged silently.

Common Questions
Can foreigners operate a human pharmaceutical raw material manufacturing business in Indonesia?
Yes. KBLI 21011 (Industri Bahan Baku Farmasi untuk Manusia) is TERBUKA — open to 100% foreign ownership via PT PMA. No local Indonesian partner required. (Source: Perpres 10/2021 as amended by Perpres 49/2021 — the investment-list annexes predate KBLI 2025; per-code crosswalk audit in progress.)
What license is required for KBLI 21011?
KBLI 21011 has a Tinggi risk classification. Required license: NIB + Izin. Processing time: 7.
What is KBLI 21011?
KBLI 21011 is the Indonesian business classification code for "Industri Bahan Baku Farmasi untuk Manusia" (Human Pharmaceutical Raw Material Manufacturing). It falls under Section C of KBLI 2025, the Indonesian Standard Industrial Classification updated by BPS (Regulation 7/2025). The June 2026 KBLI 2025 transition window has closed; operators should verify the code's current OSS/NIB treatment before relying on it for licensing, reporting, or amendments.
How did KBLI 21011 change from KBLI 2020 to 2025?
KBLI 21011 was mapped from previous code 21011 (KBLI 2020). This is a direct match — the code number and scope remained the same. The June 2026 KBLI 2025 transition window has closed. If an NIB still relies on legacy KBLI 2020 mappings, treat the migration as overdue and verify/remediate the OSS record before new license applications, amendments, LKPM, import approvals, or investor/worker sponsorship.

Related Codes

21012Section C

Human Pharmaceutical Product Manufacturing

Industri Produk Farmasi untuk Manusia

→
🏝️✅Registrable in Bali✅Open· 100% ForeignHigh Risk
21013Section C

Veterinary Pharmaceutical Product Manufacturing

Industri Produk Farmasi untuk Hewan

→
🏝️🚫Blocked in Bali (risk-class moratorium)✅Open· 100% nat'l · blocked in BaliMedium-Low Risk
21014Section C

Veterinary Pharmaceutical Raw Material Manufacturing

Industri Bahan Baku Farmasi untuk Hewan

→
🏝️✅Registrable in Bali✅Open· 100% ForeignMedium-High Risk
21015Section C

Medical Diagnostics, Bandages & Health Support Devices

Industri Alat Diagnosis Medis, Perban, Kasa, dan Penunjang Kesehatan Lainnya

→
🏝️✅Registrable in Bali✅Open· 100% ForeignHigh Risk
21021Section C

Herbal Medicine Raw Material Manufacturing, Human

Industri Bahan Baku Obat Bahan Alam untuk Manusia

→
🏝️✅Registrable in Bali✅Open· 100% ForeignHigh Risk
21022Section C★

Herbal Medicine Product Manufacturing, Human

Industri Produk Obat Bahan Alam untuk Manusia

→
🏝️✅Registrable in Bali✅Open· 100% ForeignHigh Risk
🏢

Ready to register this business?

Bali Zero handles PT PMA setup, KBLI registration, NIB, and all licensing for KBLI 21011.

PT PMA Setup

IDR 20.000.000

Company registration, KBLI, NIB, domicile

Virtual Office

IDR 5.000.000

Legal address for your PT PMA in Bali

5,000+ companies registered since 2020

Get started on WhatsApp
5k+
Clients
★ 4.9
Reviews
~15 min
Response
Talk on WhatsApp
Zantara AIOSS Intelligence System
Context21011
Ask me anything about KBLI 21011 — Human Pharmaceutical Raw Material Manufacturing. Licensing, PMA rules, what changed in 2025, or how it works in Bali.